Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 7,060.00
-50.00 (-0.70%)
At close: May 14, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 47.38 billion as of May 15, 2026. Its market cap has increased by 29.68% in one year.
Market Cap
47.38B
Enterprise Value
32.85B
Revenue
35.24B
Ranking
n/a
PE Ratio
7.16
Stock Price
7,060.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 47.38B, a decrease of -0.44%. That is a compound annual growth rate of -0.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 47.38B | - |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 250.00B |
| CG MedTech | 170.17B |
| OSTEONIC | 118.96B |
| Sewoon Medical | 111.04B |
| JW Shinyak | 95.49B |
| SCL Science | 61.74B |
| KM Corporation | 42.06B |
| MEDYSSEY Co.,Ltd | 40.69B |